Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial von Guberina, M., Eberhardt, W., Stuschke, M., Gauler, T., Heinzelmann, F., Cheufou, D., Kimmich, M., Friedel, G., Schmidberger, H., Darwiche, K., Jendrossek, V., Schuler, M., Stamatis, G., Pöttgen, C.

Volltext

Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell... von Joerger, M., von Pawel, J., Kraff, S., Fischer, J.R., Eberhardt, W., Gauler, T.C., Mueller, L., Reinmuth, N., Reck, M., Kimmich, M., Mayer, F., Kopp, H.-G., Behringer, D.M., Ko, Y.-D., Hilger, R.A., Roessler, M., Kloft, C., Henrich, A., Moritz, B., Miller, M.C., Salamone, S.J., Jaehde, U.

Volltext

3066 Pharmacokinetically (PK)-guided dosing of paclitaxel in combination with carboplatin in advanced non-small cell lung cancer (NSCLC) is gender dependent: Updated results of the... von Joerger, M, Von Pawel, J, Kraff, S, Fischer, J.R, Gauler, T, Mueller, L, Reinmuth, N, Reck, M, Kimmich, M, Frank, M, Kopp, H.G, Behringer, D, Ko, Y.D, Ralf, H, Roessler, M, Kloft, C, Henrich, A, Moritz, B, Jaehde, U

Volltext

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: 7-year follow-up of a rare clinicopathologic syndrome von Falkenstern-Ge, R. F., Kimmich, M., Friedel, G., Tannapfel, A., Neumann, V., Kohlhaeufl, M.

Volltext

Pulmonary Adenocarcinoma Occurring 5 Years after Resection of a Primary Pancreatic Adenocarcinoma : A Relevant Differential Diagnosis von Falkenstern-Ge, R. F., Wohlleber, M., Kimmich, M., Huettl, K., Friedel, G., Ott, G., Kohlhäufl, M.

Volltext

Lung Metastasis of Primary Alveolar Soft-Part Sarcoma Occurring 20 Years after Initial Treatment von Kimmich, M., Falkenstern-Ge, R. F., Wohlleber, M., Grabner, A., Friedel, G., Ott, G., Leuschner, Ivo, Kohlhäufl, M.

Volltext

Kinetics of the Ag/KNO3/CaCO3 Catalyzed Aerobic Propylene Epoxidation and Effects of CO2 von Specht, Sarah E., Phivilay, Somphonh P., Chieregato, Alessandro, Nagy, Sandor, Kimmich, Barbara F. M., Hermans, Ive

Volltext

Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients... von Hoffknecht, Petra, Tufman, Amanda, Wehler, Thomas, Pelzer, Theo, Wiewrodt, Rainer, Schütz, Martin, Serke, Monika, Stöhlmacher-Williams, Jan, Märten, Angela, Maria Huber, Rudolf, Dickgreber, Nicolas J.

Volltext

1442P DURATION: A multicenter randomized phase II trial investigating sequential mono- (mCTX) or doublet-chemotherapy (dCTX) followed by durvalumab (D) in older or frail patients w... von Kuon, J.B., Blasi, M., Kokowski, K., Faehling, M., Schuette, W., Christoph, D.C.C., Kimmich, M., Engel-Riedel, W., Fischer, J.R., Lehmann, M., Ulmer, M., Schuett, P., Moosmann, N., Meyer zum Büschenfelde, C., Griesinger, F., Schneider, M., Behnisch, R., Stenzinger, A., Christopoulos, P., Thomas, M.

Volltext

Pleural Mesothelioma Presenting as Periumbilical Metastasis : The First Clinical Documentation von Falkenstern-Ge, R. F., Kohlhäufl, M., Ott, G., Kimmich, M., Bode-Erdmann, S., Friedel, G.

Volltext

1021P DURATION - a phase II randomized trial in older / frail patients (pts) with advanced non-small cell lung cancer (NSCLC) comparing chemotherapy (CTX, 4 cycles) with CTX (2 cyc... von Kuon, J.B., Blasi, M., Kokowski, K., Faehling, M., Schuette, W., Christoph, D.C.C., Kimmich, M., Engel-Riedel, W., Fischer, J., Lehmann, M., Ulmer, M., Schuett, P., Moosmann, N., Meyer zum Bueschenfelde, C., Griesinger, F., Schneider, M., Behnisch, R., Stenzinger, A., Christopoulos, P., Thomas, M.

Volltext

OA02.03 Amivantamab Plus Lazertinib vs Osimertinib in First-line EGFR-mutant Advanced NSCLC: Longer Follow-up of the MARIPOSA Study von Gadgeel, S., Cho, B.C., Lu, S., Felip, E., Hayashi, H., Spira, A.I., Besse, B., Thomas, M., Owen, S., Kim, Y.J., Lee, S.-H., Mourão Dias, J., Lee, Y.-G., Zhao, Y., Fang, Y., Girard, N., Liu, Z., Sun, P., Oliveira, S.C. Sousa, Shen, H., Paz-Ares, L., Matsumoto, S., Tanaka, H., Ahmad, A.R., Andabekov, T., Sunpaweravong, P., Ozyilkan, O., Yang, J.C.-H., Gottfried, M., Hernandez, O., Kimmich, M., Cortinovis, D., Kaen, D.L., Montes, L.V. García, Popat, S., Newsom-Davis, T., Xie, J., Sun, T., Fennema, E., Daksh, M., Ennis, M., Sethi, S., Bauml, J.M., Nguyen, D.

Volltext

1246P Hybrid capture-based assays in primary diagnostics of NSCLC patients: Results from the NEOlung study von Jori, B., Gautschi, O., Kimmich, M., Beaucaire Danel, S., Reinmuth, N., Garrido Lopez, P., Cappuzzo, F., Forster, M., Patel, K., Grohe, C., Müller, A., Wesseler, C., Menon, R., Müller, J., Mariotti, E., Brinkmann, J., Heukamp, L., Griesinger, F.

Volltext

MA06.08 Long-term Survival and Competing Risks of Death in the ESPATUE Randomized Phase-III Trial in Stage III NSCLC von Eberhardt, W.E.E., Poettgen, C., Gauler, T.C., Schulte, C., Friedel, G., Kopp, H.-G., Fischer, B., Schmidberger, H., Kimmich, M., Budach, W., Cordes, S., Metzenmacher, M., de Los Rios, R. Hepp, Spengler, W., De Ruysscher, D., Belka, C., Welter, S., Brintrup, D. Luetke, Guberina, M., Oezkan, F., Darwiche, K., Schuler, M., Jöckel, K.-H., Aigner, C., Stamatis, G., Stuschke, M.

Volltext

Afatinib in Non‐Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors von Schumann, Christian, Sebastian, Martin, Sadjadian, Parvis, Märten, Angela, Abdollahi, A., Aries, S.P., Arntzen, C., Atmaca, A., Basara, N., Borchard, B., Bos, M., Brugger, W., Budweiser, S., Corduan, K., Cortes‐Incio, D., Dallmeier, B., Denzlinger, C., Dittrich, I., Engel‐Riedel, W., Faehling, M., Fertl, A., Fischer, J.R., Fleckenstein, D., Folprecht, G., Forstbauer, A., France, Y., Frickhofen, N., Gardizi, M., Gauler, T., Gessner, C., Gökkurt, E., Görner, M., Grah, C., Greeve, J., Greiner, J., Grohé, C., Grüning, W., Guggenberger, D., Heinrich, B., Hense, G., Hoiczyk, M., Huber, R.M., Illerhaus, G., Jacobs, G., Jung, P., Kern, J., Kersten, J., Kiehl, M., Kisro, J., Knipp, H., Ko, Y.D., Koch, J.U., Koehne, C.H., Kollmeier, J., Kommer, A., Körber, W., Krause, G., Krügel, R., Leistner, R., Liebers, U., Lommatzsch, M., Maintz, C., Mohr, M., Neumeister, W., Overbeck, T., Panse, J., Pelzer, T., Peters, K., Planker, M., Reissig, A., Ritter, M., Sadjadian, P., Sandritter, B., Schatz, M., Scheffler, M., Schmid‐Bindert, G., Schneider, C.P., Schneider‐Kappus, W., Schreiber, J., Schütte, W., Schütz, S., Sebastian, M., Serke, M., Staiger, H., Stehle, I., Stengele, K., Stöhlmacher‐Williams, J., Strapatsas, T., Sulzbach, B., Tessmer, A., Thomas, M., Ukena, D., Wagner, B., Wagner‐Hug, D., Witt, C., Wohlleber, M., Wolf, J., Wricke, K., Zaba, O., Zander, I.

Volltext

Molybdenum Carbonyl Complexes in the Solvent-Free Catalytic Hydrogenation of Ketones von Kimmich, Barbara F. M, Fagan, Paul J, Hauptman, Elisabeth, Marshall, William J, Bullock, R. Morris

Volltext

Synthesis and Characterization of Boron-Containing Ferrocenyl Ligands for Asymmetric Catalysis von Kimmich, Barbara F. M, Landis, Clark R, Powell, Douglas R

Volltext

Experience With Afatinib in Patients With Non‐Small Cell Lung Cancer Progressing After Clinical Benefit From Gefitinib and Erlotinib von Schuler, Martin, Fischer, Jürgen R., Grohé, Christian, Gütz, Sylvia, Thomas, Michael, Kimmich, Martin, Schneider, Claus‐Peter, Laack, Eckart, Märten, Angela

Volltext

Protonation of (PCP)PtH To Give a Dihydrogen Complex von Kimmich, Barbara F. M, Bullock, R. Morris

Volltext

Kinetics of the Ag/KNO 3 /CaCO 3 Catalyzed Aerobic Propylene Epoxidation and Effects of CO 2 von Specht, Sarah E., Phivilay, Somphonh P., Chieregato, Alessandro, Nagy, Sandor, Kimmich, Barbara F. M., Hermans, Ive

Volltext